Skip to main content
Smart Investors Daily
HK

NASDAQ · HKPD

Hong Kong Pharma Digital Technology Holdings Limited

Industrials · Integrated Freight & Logistics

$0.13

Down-$0.01 (-4.06%)

Updated Sep 10, 2026, 7:10 PM

SID Score

2.5/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
8.62M
P/E ratio
-299.74
Dividend yield
0.00%
52-week range
$0.12 – $1.82
Volume
540.1K
Avg. volume
166.7K

Price performance

HKPD price history

1M range · 20 trading sessions · Daily adjusted prices

HKPD closed at $0.13 after 20 trading sessions, down 69.02% for the selected period.

Last close
$0.13
Period change
-69.02%
Period low
$0.13
Period high
$0.42
Daily close
View OHLC price history
HKPD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 9, 2026$0.1299$0.1299$0.1238$0.1282540.1K
Sep 8, 2026$0.1238$0.13$0.1238$0.12861.13M
Sep 4, 2026$0.1373$0.1398$0.1237$0.12762.35M
Sep 3, 2026$0.1529$0.1534$0.136$0.144.51M
Sep 2, 2026$0.1588$0.1737$0.1402$0.15213.98M
Sep 1, 2026$0.3247$0.4672$0.1508$0.181599.01M
Aug 31, 2026$0.3526$0.3632$0.32$0.333324.64K
Aug 28, 2026$0.391$0.3999$0.3439$0.347215.29K
Aug 27, 2026$0.3811$0.4198$0.3811$0.40615.28K
Aug 26, 2026$0.39$0.4199$0.3764$0.37748.21K
Aug 25, 2026$0.384$0.399$0.3799$0.39819.06K
Aug 24, 2026$0.3976$0.4183$0.37$0.372314.01K
Aug 21, 2026$0.3999$0.4189$0.3899$0.4087120.71K
Aug 20, 2026$0.3994$0.42$0.3707$0.40911.59K
Aug 19, 2026$0.4149$0.42$0.3725$0.38716.62K
Aug 18, 2026$0.3921$0.417$0.3921$0.402640.55K
Aug 17, 2026$0.42$0.4351$0.3963$0.4121825.8K
Aug 14, 2026$0.411$0.422$0.4001$0.419970.86K
Aug 13, 2026$0.3939$0.4397$0.3842$0.42130.14K
Aug 12, 2026$0.42$0.42$0.4078$0.413840.43K

Latest HKPD news

The latest Smart Investors Daily articles mentioning HKPD.

HKPD research

Overview

Company profile and research snapshot.

Company profile

Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 16, 2026

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain c

Benzinga · Jun 30, 2026

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

Gainers VisionWave Holdings (NASDAQ:VWAV) shares moved upwards by 83.5% to $8.48 during Tuesday's pre-market session. The company's market cap stands at $123.4 million. Baiya International Group (NASDAQ:BIYA)

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.